Directorio
ENRIQUE DE ALAVA CASADO
䲹ٱǰí
Profesor Titular de Universidad (Pza. V)
Contacto
Correo electrónico
Departamento
Á
Anatomía Patológica
Docencia
Asignaturas que imparte
Աپó
Grupo de investigación
Patología Molecular del Cáncer Sólido (PATMOL)
Proyectos y contratos de investigación
Nuevas dianas terapéuticas en el sarcoma de Ewing a través del estudio del proceso metastasico (PI17/00464 - Investigador Principal Consolidado)
Caracterización molecular de fusiones génicas en el sarcoma del estroma endometrial: Hacia una medicina de precisión. (PE-0186-2018 - Investigador Principal Consolidado)
New insights into the Desmoplastic small round cell tumour: comprehensive molecular characterization to identify therapeutic targets and new biomarker (Participante)
Evaluación del potencial clínico de las vesículas extracelulares en la monitorización de la respuesta a fármacos y la detección de enfermedad mínima r (PI-0040-2017 - Investigador/a)
New therapeutic targets in Ewing sarcoma: a study on the microenvironment (PI14/01466 - Investigador/a)
RELEVANCE OF ENDOGLIN IN THE PATHOGENESIS OF EWING SARCOMA: DEVELOPMENT OF INNOVATIVE THERAPEUTICS ¿ ENDOWING (RTC-2014-2102-1 - Investigador Principal Consolidado)
Search, validation, and clinical translation of therapeutic targets in Ewing sarcoma (PI1100018 - Investigador Principal Consolidado)
PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalised translational medicine (PROVABES) (PI12/03102 - Investigador Principal Consolidado)
Estudio Preclínico y Propuesta de Estudio Clínico de la Combinación de Pevonedistat (Mln4924) Con Doxorrubicina, Gemcitabina o Bmn673 (Inhibidor de Pa (Investigador/a)
Búsqueda, validación y traslación a la clínica de nuevas dianas terapeúticas a partir de los estudios genómicos y epigenómicos en Sarcoma de Ewing (Coordinador)
Investigator-driven treatment trials for rare cancers, European Clinical trials in Rare Sarcomas within an integrated translational trial network (HEALTH.2011.2.4.1-1 - Coordinador)
International Clinical Trials to Improve Survival from Ewing Sarcoma (ECC) Proyect ID: 602856 (FP7-HEALTH.2013.2.4.1-1 - Coordinador)
Search, validation, and clinical translation of new therapeutic targets in Ewing sarcoma terapéuticas after integrative genomics and epigenomics in Ew (GCB13131578DE Á - Coordinador)
Asistencia a congresos
Diaz-Martin, Juan;Biscuola-, Michele;Aguado, Elena;Delgado-García, Mercedes;Marcilla-Plaza, David;de Álava, Enrique:
Experience in differential diagnosis of Ewing Sarcoma and Ewing-like Sarcoma by targeted RNA-seq. Poster en Congreso. CTOS 2018 Annual meeting. Rome, Italy. 2018
Experience in differential diagnosis of Ewing Sarcoma and Ewing-like Sarcoma by targeted RNA-seq. Poster en Congreso. CTOS 2018 Annual meeting. Rome, Italy. 2018
Marti-Martin-consuegra, Juan Manuel;Amé, Jean Christophe;Dantzer, Françoise ;King, George L.;Dziedzic, Klaudia;Berra, Edurne;de Álava, Enrique;Monteiro, Ana;Oliver-Pozo, Francisco Javier;García-Díaz, Ángel;O'Valle-Ravassa, Francisco J.;Lund-nielsen, Michael;Gonzalez-Flores, Ariannys;LÓPEZ-JIMÉNEZ, LAURA MARÍA;Carlevaris, Onintza;Delgado, Daniel;Rodriguez-Vargas, Jose Manuel:
PARP1 modifies postranslationally HIF-1 and induces selective HIF-1 activation. Poster en Congreso. IV REUNIÓN DEL GRUPO ESPAÑOL DE HIPOXIA. GRANADA, PARQUE DE LAS CIENCIAS. 2018
PARP1 modifies postranslationally HIF-1 and induces selective HIF-1 activation. Poster en Congreso. IV REUNIÓN DEL GRUPO ESPAÑOL DE HIPOXIA. GRANADA, PARQUE DE LAS CIENCIAS. 2018
de Álava, Enrique;Diaz-Martin, Juan;Biscuola-, Michele;Aguado, Elena;Marcilla-Plaza, David:
Targeted RNA-seq of gene fusions helps in the differential diagnosis of Ewing Sarcoma and Ewing-like Sarcoma. Comunicación en congreso. XXXII International Academy of Pathology Congress. Amman, Jordan. 2018
Targeted RNA-seq of gene fusions helps in the differential diagnosis of Ewing Sarcoma and Ewing-like Sarcoma. Comunicación en congreso. XXXII International Academy of Pathology Congress. Amman, Jordan. 2018
de Álava, Enrique;Diaz-Martin, Juan;Aguado, Elena;Biscuola-, Michele;Marcilla-Plaza, David:
Detection of NAB2-STAT6 gene fusions by targeted RNA-seq can be of help to diagnose solitary fibrous tumor. Comunicación en congreso. XXXII International Academy of Pathology Congress. Amman, Jordan. 2018
Detection of NAB2-STAT6 gene fusions by targeted RNA-seq can be of help to diagnose solitary fibrous tumor. Comunicación en congreso. XXXII International Academy of Pathology Congress. Amman, Jordan. 2018
Monteiro, Ana;Diaz-Martin, Juan;Jordán , María Del Carmen ;de Álava, Enrique:
PO-459¿Unravelling endoglin as a potential therapeutic target for the treatment of uveal melanoma. Poster en Congreso. 25th Biennial Congress of the European Association for Cancer Research. Amesterdam. 2018
PO-459¿Unravelling endoglin as a potential therapeutic target for the treatment of uveal melanoma. Poster en Congreso. 25th Biennial Congress of the European Association for Cancer Research. Amesterdam. 2018
Puerto - Camacho, Pilar;Diaz-Martin, Juan;Lamhamedi-cherradi, Salah;Schadler, Keri;Fabre, Myriam;Ludwig, Joseph A.;de Álava, Enrique;Menegaz, Brian A.;Monteiro, Ana;Ordóñez, José Luis;Domínguez, Saioa;Jordán , María Del Carmen ;Biscuola-, Michele;Robles-Frias, Maria Josefa;López-álvarez, María:
Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Poster en Congreso. CTOS Annual Meeting 2016. , - Lisboa, Portugal. 2016
Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Poster en Congreso. CTOS Annual Meeting 2016. , - Lisboa, Portugal. 2016
Rodríguez, Pablo;Romero-Pérez, Laura;García-Mejías, Rosa María;García, Daniel José;Monteiro, Ana;Hontecillas, Lourdes;Diaz-Martin, Juan;de Álava, Enrique:
DEREGULATION OF HIPPO TUMOR SUPRESSOR PATHWAY IN EWING SARCOMA . Poster en Congreso. DEREGULATION OF HIPPO TUMOR SUPRESSOR PATHWAY IN EWING SARCOMA . , - Lisboa, Portugal, Portugal. 2016
DEREGULATION OF HIPPO TUMOR SUPRESSOR PATHWAY IN EWING SARCOMA . Poster en Congreso. DEREGULATION OF HIPPO TUMOR SUPRESSOR PATHWAY IN EWING SARCOMA . , - Lisboa, Portugal, Portugal. 2016
Hontecillas, Lourdes;García, Daniel José;Rodríguez, Pablo;García-Mejías, Rosa María;Pascual-pastó, Guillem;Montero-carcaboso, Angel;Romero-Pérez, Laura;Diaz-Martin, Juan;de Álava, Enrique:
Combination of epigeneic drugs (SAHA-HCI2509) synergistically affects proliferation in Ewing Sarcoma. Poster en Congreso. Connective Tissue Oncology Society 2016 Annual Meeting. Lisboa, Portugal. 2016
Combination of epigeneic drugs (SAHA-HCI2509) synergistically affects proliferation in Ewing Sarcoma. Poster en Congreso. Connective Tissue Oncology Society 2016 Annual Meeting. Lisboa, Portugal. 2016
García, Daniel José;Hontecillas, Lourdes;Rodríguez, Pablo;García-Mejías, Rosa María;Diaz-Martin, Juan;Romero-Pérez, Laura;de Álava, Enrique:
PRECLINICAL STUDY OF THE COMBINATION OF PEVONEDISTAT WITH DOXORUBICIN, GEMCITABINE OR BMN673 IN EWING SARCOMA. Poster en Congreso. CTOS 2016 Annual meeting. , - Lisboa, Portugal. 2016
PRECLINICAL STUDY OF THE COMBINATION OF PEVONEDISTAT WITH DOXORUBICIN, GEMCITABINE OR BMN673 IN EWING SARCOMA. Poster en Congreso. CTOS 2016 Annual meeting. , - Lisboa, Portugal. 2016
Puerto - Camacho, Pilar;de Álava, Enrique;Monteiro, Ana;Ordóñez, José Luis;Robles-Frias, Maria Josefa;Domínguez, Saioa;Jordán , María Del Carmen ;Biscuola-, Michele;López-álvarez, María;Fabre, Myriam:
Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Poster en Congreso. Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Manchester, Greater Manchester, Reino Unido, Reino Unido. 2016
Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Poster en Congreso. Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Manchester, Greater Manchester, Reino Unido, Reino Unido. 2016
Valenzuela-villatoro, Marina;Lavado-Roldán, Ángela;Bejarano-garcía, José Antonio;Robles-Frias, Maria Josefa;Álvarez, María Isabel;de Álava, Enrique;Piruat-Palomo, Jose Ignacio;Perez-Simon, Jose Antonio;Fernandez-Chacon, Rafael:
Abnormal hematopoiesis in knock-out mice lacking Cysteine String Protein-a (CSP-a). Poster en Congreso. Abnormal hematopoiesis in knock-out mice lacking Cysteine String Protein-a (CSP-a). Sevilla. 2016
Abnormal hematopoiesis in knock-out mice lacking Cysteine String Protein-a (CSP-a). Poster en Congreso. Abnormal hematopoiesis in knock-out mice lacking Cysteine String Protein-a (CSP-a). Sevilla. 2016
Valenzuela-villatoro, Marina;Lavado-Roldán, Ángela;Bejarano-garcía, José Antonio;Robles-Frias, Maria Josefa;Álvarez, María Isabel;de Álava, Enrique;Piruat-Palomo, Jose Ignacio;Perez-Simon, Jose Antonio;Fernandez-Chacon, Rafael:
Abnormal hematopoiesis in knock-out mice lacking Cysteine String Protein-a (CSP-a). Poster en Congreso. II Seville Molecular Medicine Workshop Cell Therapy, Molecular Mechanisms and Clinical Translation. Sevilla. 2016
Abnormal hematopoiesis in knock-out mice lacking Cysteine String Protein-a (CSP-a). Poster en Congreso. II Seville Molecular Medicine Workshop Cell Therapy, Molecular Mechanisms and Clinical Translation. Sevilla. 2016
Monteiro-amaral, Ana;de Álava, Enrique;Puerto - Camacho, Pilar;Robles-Frias, Maria Josefa;Domínguez, Saioa;Jordán , María Del Carmen ;Biscuola-, Michele;Diaz-Martin, Juan;Fabre, Myriam:
Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Poster en Congreso. Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Oporto, Norte, Portugal. 2016
Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Poster en Congreso. Targeting Ewing Sarcoma Cells and the tumor microenvironment with OMTX003 Anti-Endoglin Monoclonal Antibodies. Oporto, Norte, Portugal. 2016
de Álava, Enrique;Monteiro, Ana:
DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on cl. Comunicación en congreso. AACR Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship. Fort Lauderdale, Florida, USA.. 2015
DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on cl. Comunicación en congreso. AACR Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship. Fort Lauderdale, Florida, USA.. 2015
de Álava, Enrique;García, Daniel José:
RELEVANCE OF COPY NUMBER ALTERATIONS IN EWING SARCOMA: GAIN OF 1Q DEFINES A SUBSET OF PATIENTS WITH WORSE OUTCOME, PROBABLY CAUSED BY DTL/CDT2 OVEREXP. Poster en Congreso. 21ST MEETING OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH (EACR). NORUEGA. 2010
RELEVANCE OF COPY NUMBER ALTERATIONS IN EWING SARCOMA: GAIN OF 1Q DEFINES A SUBSET OF PATIENTS WITH WORSE OUTCOME, PROBABLY CAUSED BY DTL/CDT2 OVEREXP. Poster en Congreso. 21ST MEETING OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH (EACR). NORUEGA. 2010
Artículos publicados
Puerto - Camacho, Pilar;Alamo-Alvarez, Inmaculada;de Álava, Enrique:
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions. International Journal of Molecular Sciences. 2022. 10.3390/ijms23158657.
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions. International Journal of Molecular Sciences. 2022. 10.3390/ijms23158657.
García, Daniel José;Hontecillas, Lourdes;Morón-Civanto, Francisco Jesús;de Álava, Enrique:
An Inducible Ectopic Expression System of EWSR1-FLI1 as a Tool for Understanding Ewing Sarcoma Oncogenesis. PLoS One. 2020. Vol: 15. Núm: 6. Pág. e0234243-e0234243. 10.1371.
An Inducible Ectopic Expression System of EWSR1-FLI1 as a Tool for Understanding Ewing Sarcoma Oncogenesis. PLoS One. 2020. Vol: 15. Núm: 6. Pág. e0234243-e0234243. 10.1371.
SERRANO MJ;Exposito-Hernandez, Jose;Lopez , Javier Luis;Aguilar-Peña, Mariano;Lorente-Acosta, José Antonio;de Álava, Enrique;Garrido, M. Carmen:
From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations. Translational Lung Cancer Research. 2020. Vol: 9. Núm: 2. Pág. 180-183. 10.21037/tlcr.2020.03.07.
From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations. Translational Lung Cancer Research. 2020. Vol: 9. Núm: 2. Pág. 180-183. 10.21037/tlcr.2020.03.07.
SALGUERO-ARANDA, CARMEN;Monteiro, Ana;Olmedo, José Joaquín;Diaz-Martin, Juan;de Álava, Enrique:
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape . Cells. 2020. 10.3390/cells9040804. .
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape . Cells. 2020. 10.3390/cells9040804. .
Diaz-Martin, Juan;Biscuola-, Michele;Marcilla-Plaza, David;de Álava, Enrique:
What¿s in a name? Molecular sub¿classification of sarcomas creates fresh challenges. Journal of Pathology. 2018. 10.1002/path.5206..
What¿s in a name? Molecular sub¿classification of sarcomas creates fresh challenges. Journal of Pathology. 2018. 10.1002/path.5206..
Monteiro, Ana;Romero-Pérez, Laura;Puerto - Camacho, Pilar;de Álava, Enrique;Jordán , María Del Carmen ;Diaz-Martin, Juan:
Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma.. Clinical Cancer Research. 2018.
Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma.. Clinical Cancer Research. 2018.
Hontecillas-prieto, Lourdes;García, Daniel José;Pascual Vaca, Diego Pascual Vaca;Garcia-mejias, Rosa ;Marcilla, David ;Ramirez-villar, Gema L. ;Saez-Torres, Carmen;de Álava, Enrique:
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients. Oncotarget. 2017. 10.18632/oncotarget.14491.
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients. Oncotarget. 2017. 10.18632/oncotarget.14491.
Marcilla-Plaza, David;de Álava, Enrique:
Birth and evolution of the desmoplastic small round-cell tumor.. Seminars in Diagnostic Pathology. 2017.
Birth and evolution of the desmoplastic small round-cell tumor.. Seminars in Diagnostic Pathology. 2017.
Hontecillas, Lourdes;García, Daniel José;García-Mejías, Rosa María;Ramirez-Villar, Gema Lucia;Saez-Torres, Carmen;de Álava, Enrique:
HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients. Oncotarget. 2017. Vol: 8. Núm: 70. Pág. 115290-115303. 10.18632/oncotarget.23256.
HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients. Oncotarget. 2017. Vol: 8. Núm: 70. Pág. 115290-115303. 10.18632/oncotarget.23256.
Monteiro, Ana;de Álava, Enrique:
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. Nature Medicine. 2017.
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. Nature Medicine. 2017.
Huertas-martínez , J;Hontecillas, Lourdes;de Álava, Enrique;Tirado, Om:
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.. Cancer Letters. 2017. 10.1016/j.canlet.2016.11.020.
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.. Cancer Letters. 2017. 10.1016/j.canlet.2016.11.020.
Hernandez-muñoz, I;Hontecillas, Lourdes;de Álava, Enrique;Mora, J;García, Daniel José:
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-¿B pathway, independently of the fusion oncoprotein. Oncotarget. 2016. RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-¿B pathway, independently of the fusion oncoprotein.
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-¿B pathway, independently of the fusion oncoprotein. Oncotarget. 2016. RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-¿B pathway, independently of the fusion oncoprotein.
Madoz-gúrpide, Juan;de Álava, Enrique;Hontecillas, Lourdes;García, Daniel José;Monteiro, Ana:
Proteomic Profiling of Ewing Sarcoma Reveals a Role for TRAF6 in Proliferation and Ribonucleoproteins/RNA Processing. Journal of Proteomics and Bioinformatics. 2016.
Proteomic Profiling of Ewing Sarcoma Reveals a Role for TRAF6 in Proliferation and Ribonucleoproteins/RNA Processing. Journal of Proteomics and Bioinformatics. 2016.
Del Carmen, Sofía ;de Álava, Enrique;Gatius, Sonia ; Baena, José Antonio; Gonzalez, Oscar:
Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the. Human Pathology. 2015.
Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the. Human Pathology. 2015.
Amaral, Ana Teresa;de Álava, Enrique;Scotlandi, Katia ;Ordóñez, Jose Luis :
Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents. Clinical Cancer Research. 2015.
Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents. Clinical Cancer Research. 2015.
Monteiro, Ana;de Álava, Enrique;Ordóñez-garcia, Jose Luis ;Carcaboso, Angel ;Herrero-martín, David:
The PARP inhibitor olaparib enhances the sensitivity of ewing sarcoma to trabectedin. Oncotarget. 2015.
The PARP inhibitor olaparib enhances the sensitivity of ewing sarcoma to trabectedin. Oncotarget. 2015.
Monteiro, Ana;Ordoñez, Jose Luis ;Otero-motta, Ana Pastora; García-domínguez, Daniel J;Sevillano, Victoria ;de Álava, Enrique:
Advances in Anatomic Pathology. Advances in Anatomic Pathology. 2014.
Advances in Anatomic Pathology. Advances in Anatomic Pathology. 2014.
Monteiro, Ana; Scotlandi, Katia ;de Álava, Enrique;Ordeñez, Jose Luis ;Biscuola, Muchele;Osuna-Jimenez, Daniel:
Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications. PLoS One. 2014.
Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications. PLoS One. 2014.
Mackintosh, Carlos ;García, Daniel José;Odoñez, Jose Luis ;Ginel-picardo, Alicia ;de Álava, Enrique:
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells. Oncogene. 2013.
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells. Oncogene. 2013.
Mackintos, Carlos;de Álava, Enrique;Ordoñez, Jose Luis ;García, Daniel José;Sevillano , Victoria ;Scotlandi, Katia :
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene. 2012.
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene. 2012.
Patentes
de Álava, Enrique: MÉTODO PARA EL PRONÓSTICO DE TUMORES DEL DESARROLLO Y USO DE INHIBIDORES DE LA METILACIÓN GÉNICA PARA EL TRATAMIENTO DE LOS MISMOS. Número de patente:
García, Daniel José;de Álava, Enrique: METHODS OF PROGNOSTICATING AND TREATING EWING SARCOMA/PNET AND OTHER NEOPLASMS. Número de patente:
Tesis dirigidas o codirigidas
Monteiro, Ana:
Patogenesis del Sarcoma de Ewing: implicacion para nu evas estrategias terapeuticas . Tesis Doctoral. 2014
Patogenesis del Sarcoma de Ewing: implicacion para nu evas estrategias terapeuticas . Tesis Doctoral. 2014
García, Daniel José:
Inhibición de las rutas de ubiquitinación de proteí nas dependientes de complejos cullin-RING ligasa en sarcoma de Ewing: validación prec. Tesis Doctoral. 2013
Inhibición de las rutas de ubiquitinación de proteí nas dependientes de complejos cullin-RING ligasa en sarcoma de Ewing: validación prec. Tesis Doctoral. 2013
(Doctorando no grabado):
Patología Molecular del cáncer gástrico. Tesis Doctoral. 2013
Patología Molecular del cáncer gástrico. Tesis Doctoral. 2013
(Doctorando no grabado):
Inhibición de las rutas de ubiquitinación de proteínas dependientes de complejos cullin-RING ligasa en sarcoma de Ewing: validación preclínica y carac. Tesis Doctoral. 2013
Inhibición de las rutas de ubiquitinación de proteínas dependientes de complejos cullin-RING ligasa en sarcoma de Ewing: validación preclínica y carac. Tesis Doctoral. 2013
(Doctorando no grabado):
dentificación y caracterización de subtipos de enf ermedad en sarcoma de Ewing . Tesis Doctoral. 2010
dentificación y caracterización de subtipos de enf ermedad en sarcoma de Ewing . Tesis Doctoral. 2010
(Doctorando no grabado):
Estudio del valor patogénico de la expresión y ruta de señalización de KIT e IGF1R en sarcoma de Ewing. ¿Nuevas posibles dianas terapéuticas. Tesis Doctoral. 2008
Estudio del valor patogénico de la expresión y ruta de señalización de KIT e IGF1R en sarcoma de Ewing. ¿Nuevas posibles dianas terapéuticas. Tesis Doctoral. 2008
(Doctorando no grabado):
Análisis de la función de EWS-FLI1 en la patogenia d el sarcoma de Ewing . Tesis Doctoral. 2008
Análisis de la función de EWS-FLI1 en la patogenia d el sarcoma de Ewing . Tesis Doctoral. 2008
(Doctorando no grabado):
Estudio de factores pronósticos y de progresión en el tumor de Ewing. Tesis Doctoral. 2004
Estudio de factores pronósticos y de progresión en el tumor de Ewing. Tesis Doctoral. 2004
(Doctorando no grabado):
Estudio de la expresión de las metaloproteinasas de la matriz y sus inhibidores tisulares y su valor pronóstico en pacientes diagnosticados de tumor r. Tesis Doctoral. 2003
Estudio de la expresión de las metaloproteinasas de la matriz y sus inhibidores tisulares y su valor pronóstico en pacientes diagnosticados de tumor r. Tesis Doctoral. 2003
